Vanguard Fiduciary Trust
ORGO icon

Vanguard Fiduciary Trust’s Organogenesis Holdings ORGO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
495,363
-3,089
-0.6% -$7.55K ﹤0.01% 2944
2026
Q1 		$1.18M Buy
+498,452
New +$1.73M ﹤0.01% 2839

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vanguard Fiduciary Trust's ORGO Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Organogenesis Holdings (ORGO) stake by 0.62% in Q2 2026, selling an estimated $7.55K and leaving 495,363 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2944.

Vanguard Fiduciary Trust first reported a position in ORGO in Q1 2026 and has held it in 2 quarters since. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Vanguard Fiduciary Trust held 495,363 shares of Organogenesis Holdings worth $1.2M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 3,089 Organogenesis Holdings shares in Q2 2026, an estimated $7.55K.
  • Organogenesis Holdings made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2944 holding.
  • Vanguard Fiduciary Trust first reported a position in Organogenesis Holdings in Q1 2026 and has held it in 2 quarters since.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.